Ofloksasiini

Ofloksasiini is a synthetic chemotherapeutic antibiotic of the fluoroquinolone class. It is a broad-spectrum agent that exhibits activity against a wide range of Gram-positive and Gram-negative bacteria. Ofloksasiini works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. This inhibition leads to DNA strand breaks and ultimately bacterial cell death.

It is used to treat various bacterial infections, including those of the respiratory tract, urinary tract, skin, and soft tissues. Ofloksasiini is available in oral and ophthalmic formulations. The oral form is typically prescribed for systemic infections, while the ophthalmic solution is used for bacterial conjunctivitis.

Common side effects associated with ofloksasiini include nausea, diarrhea, headache, and dizziness. More serious, though less common, adverse effects can include tendonitis and tendon rupture, particularly in older adults and those taking corticosteroids. Like other fluoroquinolones, ofloksasiini carries a warning regarding potential for serious side effects affecting the tendons, muscles, joints, nerves, and central nervous system. It is important to use ofloksasiini only as prescribed by a healthcare professional and to report any unusual symptoms.